Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder
- S. J. Pittock
- , A. Berthele
- , K. Fujihara
- , H. J. Kim
- , M. Levy
- , J. Palace
- , I. Nakashima
- , M. Terzi
- , N. Totolyan
- , S. Viswanathan
- , K. C. Wang
- , A. Pace
- , K. P. Fujita
- , R. Armstrong
- , D. M. Wingerchuk
- Mayo Clinic
- Tohoku University Graduate School of Medicine
- Fukushima Medical University
- Southern TOHOKU Research Institute for Neuroscience (STRINS)
- National Cancer Center, Gyeonggi
- Johns Hopkins University
- Massachusetts General Hospital
- John Radcliffe Hospital
- Tohoku Medical and Pharmaceutical University
- Ondokuz Mayis University
- St. Petersburg State Medical Pavlov University
- Hospital Kuala Lumpur
- National Yang-Ming University Taiwan
- Alexion Pharmaceuticals, Inc.
- Mayo Clinic Scottsdale-Phoenix, Arizona
Research output: Contribution to journal › Article › peer-review
732
Scopus
citations